Activation of mTOR closely correlates with cancer progression, resistance to chemotherapy, and poor prognosis.54 Furthermore, metformin may also promote tumor cell senescence through suppressing cyclin D1 expression.55 The antitumor effects have also been illustrated in animal models of CRC. Here, MTOR is linked to cancer.